• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Infectious Disease

Text message reminders increase second-dose pediatric flu vaccine uptake

byJames GrayandCordelia Ross
December 29, 2014
in Infectious Disease, Pediatrics
Reading Time: 3 mins read
Share on FacebookShare on TwitterShare on LinkedIn

1. Text message reminders to parents that contained educational information resulted in increased second-dose influenza vaccination uptake among children aged 6 months to 8 years.

2. Parents receiving text message reminders were more likely to get their child’s second dose of influenza vaccine within 2 weeks of its due date compared to parents who received written reminders.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Less than half of children requiring 2 doses of influenza vaccine receive their second dose. The use of text message reminders has been shown to be effective in increasing first-dose vaccination of children, so this study sought to examine the effect of these reminders on second-dose influenza vaccination. Children in the text message reminder group were significantly more likely to receive the required second dose of influenza vaccine when compared to children receiving traditional written reminders in the mail. In addition, the group receiving educational text messages containing information about the importance of a second dose were even more likely to receive the second dose. Children receiving text message reminders were also more likely to be vaccinated within 2 weeks of the vaccination due date. This study focused on a largely low-income, minority population, which may limit its generalization. However, results do suggest that physicians, especially those working with low-income populations, should consider using text message reminders to improve vaccine uptake.

Click to read the study, published today in Pediatrics

Relevant Reading: Effect of a text messaging intervention on influenza vaccination in an urban, low-income pediatric and adolescent population: a randomized controlled trial.

RELATED REPORTS

First messenger RNA influenza vaccine outperforms standard-dose vaccination

2MM: Pharma Roundup – mRNA flu vaccine debuts, RAS inhibition extends pancreatic cancer survival, and new therapies advance for dermatomyositis and Tourette syndrome

FDA approvedFor influenza: mFlusiva (Influenza Vaccine, mRNA), Aug 5, 2026→

In-Depth [randomized controlled trial]: Participants included 660 individuals ages 6 months to 8 years from 3 academically-affiliated, community-based clinics in New York City who required a second influenza vaccine dose in the 2012 to 2013 flu season. They were randomly assigned to 1 of 3 groups: written reminder, conventional text messages plus written reminder, or educational text messages plus written reminder. The educational text messages included the following additional information: the child is not protected until receiving the second dose, full protection may take up to 2 weeks after the second dose, and doctors recommend a second dose. Children in both the educational text message group and the conventional text message group were significantly more likely to receive a second dose of influenza vaccine than those in the written reminder group (RR = 1.27, 95% CI 1.11-1.47 and RR = 1.17 95% CI 1.01-1.35, respectively). Children in the educational text message group were also more likely to receive their second dose within 2 weeks of its due date when compared to the written reminder group (RR=1.7, 95% CI 1.30-2.24).

More from this author: Exposure to maternal depression linked to adolescent risk behaviors, Childhood ADHD, stimulant treatment not linked with height, Healthcare-associated infections falling among critically ill children, Postresuscitation care may be needed regardless of PPV duration, School-based health centers may serve as patient-centered medical homes 

Image: CC

©2014 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. No article should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2 Minute Medicine, Inc.

Tags: Influenza vaccinetexting
Previous Post

AAP outlines best practices to improve Emergency Department flow

Next Post

2 Minute Medicine Rewind December 22 – December 28, 2014

RelatedReports

An illustration showing a vaccine vial, a protective shield, and an mRNA strand alongside influenza virus particles, symbolizing the mRNA flu vaccine.
Pharma

First messenger RNA influenza vaccine outperforms standard-dose vaccination

September 15, 2026
A variety of pharmaceutical items including a vial, capsule, molecule model, pill blister pack, petri dish with a pipette, and a graph, symbolizing drug development.
Pharma Roundup

2MM: Pharma Roundup – mRNA flu vaccine debuts, RAS inhibition extends pancreatic cancer survival, and new therapies advance for dermatomyositis and Tourette syndrome

September 15, 2026
Vaccination collage: a smiling woman with a round plaster on her upper arm beside an open cool box of capped vaccine vials
Pharma

mFlusiva becomes the first mRNA influenza vaccine approved by the FDA

August 26, 2026
Pain control after surgery collage: an older woman resting on a hospital pillow beside a teal nerve that branches at one end
Infectious Disease

Concomitant COVID-19 and influenza vaccination not linked to increased adverse events

June 29, 2026
Next Post
Circulating tumor DNA used to monitor metastatic breast cancer

2 Minute Medicine Rewind December 22 – December 28, 2014

Obesity and elevated blood pressure associated with pediatric atopic dermatitis

Ebola and Marburg vaccines safe and well tolerated in Phase 1b trial in Uganda

Ebola and Marburg vaccines safe and well tolerated in Phase 1b trial in Uganda

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Ibuprofen is associated with acute kidney injury in high-risk inpatients but not low-risk.
  • Thoracic epidural and paravertebral blockade have similar efficacy for reduction of chronic post-thoracotomy pain
  • Brepocitinib improved cutaneous sarcoidosis activity compared to placebo in phase II of BEACON trial.
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ new physician-written study summaries monthly, 12,000+ searchable
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.